ArticleJournal of the advanced practitioner in oncology2026
Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura.
Taylor P Robichaux et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.